To increase GLP-1 uptake, these oral formulations use a chemical enhancer (i.e., sodium salcaprozate, or SNAC) to increase the amount of the drug that enters the bloodstream, thus making compliance easier
Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Eli Lilly acquired Protomer Technologies in late 2024, a biotech that was working on advanced glucagon like peptide treatments
If placing in the refrigerator, place bottle inside Zip-Loc bag with desiccant inside bag - not in the bottle
Advantages of Advanced LC-MS Approaches Higher sensitivity for trace impurities Structural confirmation of complex peptide modifications Improved characterization of biosimilar GLP-1 drugs Better stability and degradation profiling These advanced technologies greatly expand the analytical capabilities available to scientists working with peptide therapeutics
Adding the GIP component improves insulin sensitivity and may help the body tolerate higher doses of the GLP-1 component
